393 related articles for article (PubMed ID: 27341343)
1. Benefits of Strategic Small-Scale Targeted Screening.
Sharlow ER
Assay Drug Dev Technol; 2016 Aug; 14(6):329-32. PubMed ID: 27341343
[TBL] [Abstract][Full Text] [Related]
2. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
3. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
[TBL] [Abstract][Full Text] [Related]
4. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
5. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
[TBL] [Abstract][Full Text] [Related]
6. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
[TBL] [Abstract][Full Text] [Related]
7. Screening Library Design.
Ashenden SK
Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
[TBL] [Abstract][Full Text] [Related]
8. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
9. Recent trends and observations in the design of high-quality screening collections.
Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
[TBL] [Abstract][Full Text] [Related]
10. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
11. GPCR profiling: from hits to leads and from genotype to phenotype.
Cvijic ME; Sum CS; Alt A; Zhang L
Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
[TBL] [Abstract][Full Text] [Related]
12. Fragment-based approaches in drug discovery and chemical biology.
Scott DE; Coyne AG; Hudson SA; Abell C
Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
[TBL] [Abstract][Full Text] [Related]
13. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
14. Evaluating and evolving a screening library in academia: the St Jude approach.
Nishiguchi G; Das S; Ochoada J; Long H; Lee RE; Rankovic Z; Shelat AA
Drug Discov Today; 2021 Apr; 26(4):1060-1069. PubMed ID: 33453364
[TBL] [Abstract][Full Text] [Related]
15. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
[TBL] [Abstract][Full Text] [Related]
16. The Interweaving of Cheminformatics and HTS.
Kümmel A; Parker CN
Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979
[TBL] [Abstract][Full Text] [Related]
17. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
[TBL] [Abstract][Full Text] [Related]
18. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
Fontana S
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
[TBL] [Abstract][Full Text] [Related]
19. Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective.
Karawajczyk A; Giordanetto F; Benningshof J; Hamza D; Kalliokoski T; Pouwer K; Morgentin R; Nelson A; Müller G; Piechot A; Tzalis D
Drug Discov Today; 2015 Nov; 20(11):1310-6. PubMed ID: 26429298
[TBL] [Abstract][Full Text] [Related]
20. Fragment screening using X-ray crystallography.
Davies TG; Tickle IJ
Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
